Streetbeat News

Earnings

AMC

AMC Entertainment Holdings (NYSE:AMC) reported Q2 sales of $1.35 billion, beating the analyst consensus estimate of $1.29 billion by 4.49 percent. This represents a 15.56 percent increase over sales of $1.17 billion in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:14 am

SQSP

Squarespace (NYSE:SQSP) reported Q2 earnings of $0.03 per share, missing the analyst consensus estimate of $0.13 by 76.92%. This is a 93.33% decrease from the same period last year. However, the company reported quarterly sales of $247.53 million, beating the analyst consensus estimate of $243.36 million by 1.71%. This is a 16.37% increase from the same period last year.

Portfolio Pulse from totan@benzinga.com

August 08, 2023 | 10:13 am

GOLD

Barrick Gold's Q2 gold production was 1.01 million ounces, a decrease of 3.5% year-over-year. The company also reported a 6% increase in gold sold and a 5% increase in the market gold price. However, the cost of sales and all-in sustaining costs for gold increased by 9% and 12% respectively. Copper production and sales also decreased by 11% and 16% respectively, while the cost of sales and all-in sustaining costs for copper increased by 35% and 9% respectively.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:12 am

MNDO

MIND C.T.I. (NASDAQ:MNDO) reported Q2 earnings of $0.06 per share, unchanged from the same period last year. The company's sales increased by 0.27% to $5.25 million from $5.24 million YoY.

Portfolio Pulse from saritha@benzinga.com

August 08, 2023 | 10:12 am

SNCE

Science 37 Holdings, Inc. (NASDAQ:SNCE) has revised its FY23 adjusted EBITDA guidance to approximately $(35.0) million, an improvement from the previously conveyed range of $(39.0) million to $(41.0) million. The company also expects FY23 revenues of $60M, slightly above the consensus of $56.94M and the prior view of $55M-$60M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:12 am

HAE

Haemonetics has updated its FY24 revenue growth forecast to 6%-9%, up from the previous 4%-7%. The company also expects its adjusted EPS to be between $3.60 and $3.90, higher than the previous guidance of $3.45-$3.75 and the consensus estimate of $3.59.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:10 am

SNCE

Science 37 Hldgs (NASDAQ:SNCE) reported Q2 adjusted EPS of $(0.07), beating the estimate of $(0.12) by 41.67%. This is a 61.11% increase over losses from the same period last year. The company also reported quarterly sales of $15.35M, beating the estimate of $12.56M by 22.22%, but this is a 20.36% decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:08 am

ATKR

Atkore has increased its FY23 adjusted EPS outlook from $17.45 - $18.35 to $18.90 - $19.30, which is higher than the estimated $18.03.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:07 am

INGR

Ingredion has increased its FY23 adjusted EPS guidance from $8.70-$9.40 to $8.80-$9.40, compared to the estimated $9.12.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:06 am

INGR

Ingredion has raised its guidance for the upcoming financial period.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:06 am